|  Help  |  About  |  Contact Us

Publication : MiR-30a inhibits osteolysis by targeting RunX2 in giant cell tumor of bone.

First Author  Huang Q Year  2014
Journal  Biochem Biophys Res Commun Volume  453
Issue  1 Pages  160-5
PubMed ID  25264196 Mgi Jnum  J:220214
Mgi Id  MGI:5632469 Doi  10.1016/j.bbrc.2014.09.076
Citation  Huang Q, et al. (2014) MiR-30a inhibits osteolysis by targeting RunX2 in giant cell tumor of bone. Biochem Biophys Res Commun 453(1):160-5
abstractText  RunX2 has been identified to crucially regulate the osteolysis in giant cell tumor of bone. MiR-30a is an intronic miRNA identified as tumor suppressor, but little is known about its role in giant tumor cell of bone. In our research, we reported miR-30a was down-regulated in GCT whereas RunX2 was highly expressed. Further research proved that miR-30a can regulate the expression of RunX2 by binding to its 3'-UTR, which influence the osteoclast differentiation and osteolysis formation. Thus, these results suggest that miR-30a could directly target RunX2 and participate in osteolysis in GCT.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

0 Bio Entities

0 Expression